BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37095522)

  • 1. Experimental studies from shake flasks to 3 L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt®-T17.
    Tingaud V; Bordes C; Al Mouazen E; Cogné C; Bolzinger MA; Lawton P
    J Biol Eng; 2023 Apr; 17(1):31. PubMed ID: 37095522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avian Cell Line DuckCelt
    Chupin C; Pizzorno A; Traversier A; Brun P; Ogonczyk-Makowska D; Padey B; Milesi C; Dulière V; Laurent E; Julien T; Galloux M; Lina B; Eléouët JF; Moreau K; Hamelin ME; Terrier O; Boivin G; Dubois J; Rosa-Calatrava M
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-cell-density cultivations to increase MVA virus production.
    Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cell density cultivation and recombinant protein production with Escherichia coli in a rocking-motion-type bioreactor.
    Glazyrina J; Materne EM; Dreher T; Storm D; Junne S; Adams T; Greller G; Neubauer P
    Microb Cell Fact; 2010 May; 9():42. PubMed ID: 20509968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the transferability of membrane-based fed-batch shake flask cultivations to stirred-tank reactor using three different protease producing Bacillus strains.
    Müller J; Hütterott A; Habicher T; Mußmann N; Büchs J
    J Biosci Bioeng; 2019 Nov; 128(5):599-605. PubMed ID: 31151898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    Tapia F; Wohlfarth D; Sandig V; Jordan I; Genzel Y; Reichl U
    PLoS One; 2019; 14(11):e0224317. PubMed ID: 31689309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
    Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
    Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process intensification strategies toward cell culture-based high-yield production of a fusogenic oncolytic virus.
    Göbel S; Jaén KE; Dorn M; Neumeyer V; Jordan I; Sandig V; Reichl U; Altomonte J; Genzel Y
    Biotechnol Bioeng; 2023 Sep; 120(9):2639-2657. PubMed ID: 36779302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Coronel J; Behrendt I; Bürgin T; Anderlei T; Sandig V; Reichl U; Genzel Y
    Vaccine; 2019 Nov; 37(47):7011-7018. PubMed ID: 31266669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Natamycin production by Streptomyces natalensis in shake-flasks and stirred tank bioreactor under batch and fed-batch conditions.
    Elsayed EA; Farid MA; El-Enshasy HA
    BMC Biotechnol; 2019 Jul; 19(1):46. PubMed ID: 31311527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of poly-β-hydroxybutyrate production by Bacillus subtilis and its use for feed-forward bioreactor studies.
    Yadav J; Patra N
    Appl Microbiol Biotechnol; 2023 Jan; 107(1):57-69. PubMed ID: 36418545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the pilot-scale fed-batch fermentation for production of
    Tang HW; Abbasiliasi S; Ng ZJ; Lee YY; Tang TK; Tan JS
    Prep Biochem Biotechnol; 2022; 52(6):691-700. PubMed ID: 34647854
    [No Abstract]   [Full Text] [Related]  

  • 15. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
    Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
    Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of characteristics of the membrane-based fed-batch shake flask.
    Philip P; Meier K; Kern D; Goldmanns J; Stockmeier F; Bähr C; Büchs J
    Microb Cell Fact; 2017 Jul; 16(1):122. PubMed ID: 28716035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved production of human type II procollagen in the yeast Pichia pastoris in shake flasks by a wireless-controlled fed-batch system.
    Ruottinen M; Bollok M; Kögler M; Neubauer A; Krause M; Hämäläinen ER; Myllyharju J; Vasala A; Neubauer P
    BMC Biotechnol; 2008 Mar; 8():33. PubMed ID: 18371201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.